Dosage ; see below
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Alvesco inhaler | Nycomed International Management GmbH | Jos Hansen (E.A) Ltd | 160mcg | 60 doses | inhaler | per actuation | KES 2,234 |
| Alvesco inhaler | Takeda | Phillips Pharmaceuticals Ltd. | 160mcg | 60 doses | inhaler | per actuation | KES 2,820.00 |
Ciclesonide Dosing: Adult
Perennial allergic rhinitis: 2 sprays (50 mcg/spray) per nostril once daily; maximum: 200 mcg/day
Seasonal allergic rhinitis: 2 sprays (50 mcg/spray) per nostril once daily; maximum: 200 mcg/day
Dosing: Pediatric
Perennial allergic rhinitis: Children ≥12 years: Refer to adult dosing:
Seasonal allergic rhinitis:
U.S. labeling: Children ≥6 year: Refer to adult dosing.
Canadian labeling: Children ≥12 years: Refer to adult dosing.
Dosing: Geriatric
Refer to adult dosing.
Dosage Forms: U.S.
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Suspension, intranasal [spray]:
Omnaris™: 50 mcg/inhalation (12.5 g) [120 metered actuations]
Generic Equivalent Available: U.S.
No
Administration
Intranasal: Shake bottle gently before using. Prime pump prior to first use (press 8 times until fine mist appears) or if spray has not been used in 4 consecutive days (press 1 time or until a fine mist appears). Blow nose to clear nostrils. Insert applicator into nostril, keeping bottle upright, and close off the other nostril. Breathe in through nose. While inhaling, press pump to release spray. Avoid spraying directly onto the nasal septum. Nasal applicator may be removed and rinsed with warm water to clean. Discard after the "discard by" date or after labeled number of doses has been used, even if bottle is not completely empty.
Use
Management of seasonal and perennial allergic rhinitis
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Simplyone | Cipla Ltd. | Lords Healthcare Ltd. | 160?g/4.5?g | 160 doses | inhaler | per actuation | KES 2,587 |
| Simplyone inhaler | Cipla Ltd. | Surgipharm Ltd | 160?g/4.5?g | 120 doses | inhaler | per actuation | KES 2,587.50 |
| Ciclesonide / Formoterol More info | |
|---|---|
| Mode Of Action | Corticosteroids activity involve inhibition of various process that are involved in the inflammation e.g. inhibition of secretion of growth factors, endothelial activating and other cytokines from lymphocytes, eosinophils, macrophages, fibroblasts, and mast cells. The net effect is to reduce the chronic inflammation in asthmatic airways. |
| Drug Indication | Bronchospasm in asthma, bronchitis, chronic bronchitis, ephysema, bronchiectasis, premature labour. |
| Drug Category | DRUGS ACTING ON RESPIRATORY SYSTEM |
| Drug Sub-Category | Inhalers |